Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with 90Yttrium microspheres

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 4, 2001, Pages 1015-1021

  Wickremesekera, J Kesara ^a   Chen, Wangxue ^a   Cannan, Rebecca J ^a   Stubbs, Richard S ^a  

^a Wakefield Hospital   (New Zealand)

Author keywords

90Y microspheres; Colorectal cancer; Cytokine; Hepatic metastasis; Selective internal radiation therapy

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICROSPHERE; TUMOR NECROSIS FACTOR ALPHA; YTTRIUM 90;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; LETHARGY; LEUKOCYTE COUNT; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER TUMOR; MALE; NAUSEA; PRIORITY JOURNAL; SAFETY; SYMPTOM; TECHNIQUE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BRACHYTHERAPY; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTE COUNT; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEOPLASM PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YTTRIUM RADIOISOTOPES;

EID: 0035869708     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01420-6     Document Type: Article

References (48)

1. Surgical treatment of colorectal metastases to the liver
2. The aetiology and management of hepatic metastases
3. Resection of liver metastases of colorectal carcinoma
4. Resection of colorectal liver metastases; 25-year experience
5. Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer; A critical review of comparative studies
6. Colorectal cancer; The challenge
7. Selective internal radiation (SIR) therapy for treatment of liver metastases; Measurement of response rate
8. Hepatic radioembolization with yttrium-90 containing glass microspheres; preliminary results and clinical follow-up (see comments)
9. Hepatic arterial chemotherapy for primary and metastatic liver cancers
10. Regression of liver metastases following treatment with yttrium-90 microspheres
11. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres; A phase I and II study
12. 90yttrium microspheres
13. Selective internal radiation therapy (SIRT) with SIR-spheres® for nonresectable colorectal liver metastases
14. Adjuvant internal radiation therapy in a model of colorectal cancer-derived hepatic metastases
15. 90yttrium-microspheres for inoperable hepatic tumors
16. Cytokine involvement in cancer anorexia/cachexia; Role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms
17. Cytokine networks in solid human tumors; Regulation of angiogenesis
18. The in vivo anti-tumor effect of human recombinant interleukin-6
19. Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells; A model for tumor vaccination
20. Modification of tumor microenvironment by cytokine gene transfer
21. High and low dose rate irradiation have opposing effects on cytokine gene expression in human glioblastoma cell lines
22. Tumor treatment and cytokines
23. The host-tumor immune conflict; From immunosuppression to resistance and destruction
24. The role of cytokines in radiation oncology
25. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer
26. Biological and clinical aspects of interleukin 6
27. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy
28. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma; Correlation with tumor burden
29. Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?
30. Monocyte release and plasma levels of interleukin-6 in patients irradiated for cancer
31. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer
32. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma
33. Prognostic value of serial serum interleukin-6 level estimation in patients with lung cancer; A preliminary report
34. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours
35. In vivo radiosensitizing effects of recombinant interleukin 6 on radiation resistant BCL-1 B-lineage leukemia cells in a murine syngeneic bone marrow transplant model system
36. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer
37. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor
38. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization
39. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma
40. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation
41. Short communication; Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF beta
42. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression
43. Hepatic parenchymal changes after intraarterial Y-90 therapy; CT findings
44. The biology of interleukin-6
45. IL-6; Insights into novel biological activities
46. Endotoxin stimulates interleukin-6 production by human Kupffer cells